期刊文献+

胆红素脑病与胆红素/血浆白蛋白比值关系探讨 被引量:14

The study of the relationship between bilirubin encephalopathy and bilirubin/albumin
原文传递
导出
摘要 目的探讨胆红素脑病与血清胆红素/血浆白蛋白比值(B/A)的关系。方法对2008年11月至2009年10月本院住院的高胆红素血症患儿进行回顾性总结.分为胆红素脑病组(病例组)与非胆红素脑病组(对照组),对住院期间的血清胆红素高峰值、血浆白蛋白以及B/A等因素之间的关系进行统计学分析。结果共收集到2253例高胆红素血症患儿,其中88例诊断胆红素脑病。病例组B/A为(1.59±0.47),对照组B/A为(0.80±0.28),差异有统计学意义(t=474.537,P=0.000)。B/A比值为0~1.0、1.1~2.0、2.1~3.0时,胆红素脑病发生率分别为0.5%、12.9%、69.2%。结论胆红素脑病的发生与B/A比值有关,B/A越高,发生胆红素脑病的危险性越大。 Objective The relationship between the bilirubin encephalopathy and bilirubin/ albumin (B/A) is discussed. Methods Cases with hyperbilirubinemia in hospital from Dec 2008 to Oct 2009, assigned into bilirubin eneephalopathy group and control group, the relationship among bilirubin peak, albumin and B/A were analyzed retrospectively. Results Of the 2253 babies with hyperbilirubinemia, A total of 88 babies developed bilirubin encephalopathy. The B/A value in bilirubin encephalopathy group was 1.59±0. 47, and control group was 0. 80 ± 0. 28, with significant differences between two groups (t = 474. 537, P = 0. 000). The incidence of bilirubin encephalopathy at different levels of B/A was different: 0-1.0, 0.5%; 1.1 -2.0, 12.9%; 2.1 -3.0, 69.2%. Conclusion The incidence of bilirubin encephalopathy is significantly associated with the levels of B/A.
出处 《中国新生儿科杂志》 CAS 2011年第5期322-324,共3页 Chinese Journal of Neonatology
关键词 胆红素脑病 胆红素/血浆白蛋白比值 新生儿高胆红素血症 Bilirubin encephalopathy Bilirubin/albumin Neonatal hyperbilirubinemia
作者简介 通讯作者:李贵南,电子信箱:lgn288@yahoo.com.cn
  • 相关文献

参考文献9

二级参考文献51

  • 1林燕,赵旭杰.新生儿健康教育对新生儿高胆红素血症的影响[J].青岛医药卫生,2007,39(2):156-158. 被引量:3
  • 2王列,王金会,陈璐.新生儿胆红素中毒性脑病33例临床分析与随访[J].陕西医学杂志,2007,36(5):554-556. 被引量:2
  • 3Funato M, Tamai H, Shimada S, et al. Vigintiphoia, unbound bilirubin and auditory brainstem responses. Pediatrics, 1994,93 : 50-53.
  • 4Amin SB, Ahlfors C, Orlando MS, et al. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics, 2001, 107: 664-670.
  • 5Ahlfors CE. Unbound bilirubin associated with kemicterus: a historical approach. J Pediatr, 2000, 137: 540-544.
  • 6Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30mg/dL or more in a large managed care organization. Pediatrics, 2003, 111 : 1303-1311.
  • 7Robertson A, Karp W, Brodersen R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand, 1991, 80: 1119-1127.
  • 8Bhutani VK, Johnson L, Sivieri FM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics, 1999,103:6-14.
  • 9American Academy of Pediatrics. Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infants 35 or more weeks of gestation. Pediatrics,2004,114:297-316.
  • 10Maisels MJ, Neonatal jaundice. Pediatr Rev ,2006,27:443-454.

共引文献199

同被引文献130

引证文献14

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部